Accelerate Protein Screening by Sequencing Protein Barcodes on Platinum®
On-demand webinar presented by Joel McDade, PhD, Sr. Commercial Business Development Manager, Quantum-Si and Bonnie Lun, PhD, Field Application Scientist
Challenges and Strategies for the Application of Omics and Spatial Technologies
A concise report featuring insights from the prominent thought leaders of Omics 2023 and Spatial 2024
A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics
On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
Clinical Development
Non-Invasive Biomarkers: Aiding Clinical Qualification of Prognostics and Monitoring Biomarkers for Liver Cirrhosis
In this Commentary, we explore how non-invasive biomarkers may be used to diagnose pre-symptomatic NASH in patients without them undergoing invasive biopsies.
Clinical Development
The Applicability of Clinical Biomarkers for NASH and Fibrosis
Archana Vijayakumar, Senior Research Scientist I of Fibrosis at Gilead, presents on understanding disease progression and therapeutic efficacy in preclinical models for NASH.
Clinical Development
Overcoming Challenges of NASH in Clinical Development
Vincent Mikol, Precision Medicine Head at Sanofi, leads a discussion on navigating the current challenges of NASH in clinical development.
Biomarker Discovery & Development
Treating the Untreatable: Unlocking Precision Medicine Biomarkers for NASH
Introducing PreciNASH, a multidisciplinary consortium strengthening the link between research outputs and clinical applications in NASH disease treatment.
Digital Biomarkers
Identifying Prognostic Biomarkers for Follicular Lymphoma
How can the spatial interactions of the tumour immune microenvironment reveal prognostic insights into Follicular Lymphoma? We ask Martin Fergie, Lecturer in Healthcare Sciences at the University of Manchester.